Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	655.30B
Revenue (ttm)	813.69B
Net Income (ttm)	16.24B
Shares Out	12.20M
EPS (ttm)	1,332.95
PE Ratio	40.29
Forward PE	n/a
Dividend	260.00 (0.47%)
Ex-Dividend Date	Nov 24, 2025

Volume	29,503
Average Volume	96,090
Open	54,400
Previous Close	53,700
Day's Range	53,500 - 55,300
52-Week Range	28,400 - 65,900
Beta	1.05
RSI	48.48
Earnings Date	Nov 10, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.